OSI Systems (OSIS) 10-Q 2 May 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 31, 2014	1-May-14
Document and Entity Information	'	'
Entity Registrant Name	'OSI SYSTEMS INC	'
Entity Central Index Key	'0001039065	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	19,941,974
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Jun. 30, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$39,848	$34,697
Accounts receivable, net	142,806	206,817
Inventories	239,026	206,213
Prepaid expenses and other current assets	93,932	78,972
Total current assets	515,612	526,699
Property and equipment, net	265,739	249,029
Goodwill	92,196	83,743
Intangible assets, net	40,725	36,603
Other assets	25,475	23,722
Total assets	939,747	919,796
Current Liabilities:	'	'
Bank lines of credit	22,000	59,000
Current portion of long-term debt	2,779	1,797
Accounts payable	73,808	97,050
Accrued payroll and related expenses	31,869	28,503
Advances from customers	39,864	37,432
Accrued warranties	11,356	12,890
Deferred revenue	62,940	18,131
Other accrued expenses and current liabilities	21,635	26,610
Total current liabilities	266,251	281,413
Long-term debt	10,847	10,673
Advances from customers	56,250	75,000
Deferred income taxes	57,163	30,248
Other long-term liabilities	47,489	44,011
Total liabilities	438,000	441,345
Commitments and contingencies (Note 8)	'	'
Stockholders' Equity:	'	'
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued or outstanding	'	'
Common stock, $0.001 par value, 100,000,000 shares authorized; 19,914,089 issued and outstanding at June 30, 2013 and 19,938,859 shares at March 31, 2014	279,994	285,001
Retained earnings	225,554	199,786
Accumulated other comprehensive loss	-3,801	-6,336
Total stockholders' equity	501,747	478,451
Total liabilities and stockholders' equity	$939,747	$919,796

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Jun. 30, 2013
CONDENSED CONSOLIDATED BALANCE SHEETS	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, authorized shares	100,000,000	100,000,000
Common stock, shares issued	19,938,859	19,914,089
Common stock, shares outstanding	19,938,859	19,914,089

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Net revenues:	'	'	'	'
Products	$139,411	$139,026	$456,861	$432,976
Services	64,545	59,383	189,777	141,176
Total net revenues	203,956	198,409	646,638	574,152
Cost of goods sold:	'	'	'	'
Products	95,620	96,156	317,994	288,988
Services	37,829	30,415	109,252	81,883
Total cost of goods sold	133,449	126,571	427,246	370,871
Gross profit	70,507	71,838	219,392	203,281
Operating expenses:	'	'	'	'
Selling, general and administrative	39,399	37,752	127,169	114,506
Research and development	10,579	12,386	32,774	35,560
Impairment, restructuring and other charges	2,507	2,286	8,925	5,009
Total operating expenses	52,485	52,424	168,868	155,075
Income from operations	18,022	19,414	50,524	48,206
Interest and other expense, net	1,370	1,341	4,343	3,823
Income before income taxes	16,652	18,073	46,181	44,383
Provision for income taxes	11,851	4,544	20,413	12,094
Net income	$4,801	$13,529	$25,768	$32,289
Net income per share:	'	'	'	'
Basic (in dollars per share)	$0.24	$0.68	$1.29	$1.62
Diluted (in dollars per share)	$0.23	$0.66	$1.25	$1.57
Shares used in per share calculation:	'	'	'	'
Basic (in shares)	19,936	19,987	19,956	19,964
Diluted (in shares)	20,548	20,555	20,585	20,578

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME	'	'	'	'
Net income	$4,801	$13,529	$25,768	$32,289
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation adjustment	247	-7,709	2,026	-2,970
Other	387	250	509	-89
Other comprehensive income (loss)	634	-7,459	2,535	-3,059
Comprehensive income	$5,435	$6,070	$28,303	$29,230

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income	$25,768	$32,289
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	40,024	17,872
Stock based compensation expense	13,975	11,482
Provision for losses on accounts receivable	604	2,508
Deferred income taxes	25,769	196
Other	196	238
Changes in operating assets and liabilities-net of business acquisitions:	'	'
Accounts receivable	68,345	-15,181
Inventories	-28,640	-4,745
Prepaid expenses and other assets	-22,211	14,819
Accounts payable	-26,680	25,283
Accrued payroll and related expenses	3,081	1,035
Advances from customers	-16,321	-9,382
Accrued warranties	-1,918	-3,538
Deferred revenue	43,363	-5,471
Other accrued expenses and liabilities	-1,529	-10,158
Net cash provided by operating activities	123,826	57,247
Cash flows from investing activities:	'	'
Acquisition of property and equipment	-48,133	-139,429
Acquisition of businesses	-11,640	-6,087
Acquisition of intangible and other assets	-4,213	-3,773
Net cash used in investing activities	-63,986	-149,289
Cash flows from financing activities:	'	'
Net borrowings (repayments) on bank lines of credit	-37,000	55,000
Proceeds from long-term debt	3,220	11,100
Payments on long-term debt	-2,952	-824
Proceeds from exercise of stock options and employee stock purchase plan	1,501	4,615
Repurchase of common shares	-12,056	-10,444
Taxes paid related to net share settlements of equity awards	-8,427	-10,301
Net cash provided by (used in) financing activities	-55,714	49,146
Effect of exchange rate changes on cash	1,025	-876
Net increase (decrease) in cash and cash equivalents	5,151	-43,772
Cash and cash equivalents-beginning of period	34,697	91,452
Cash and cash equivalents-end of period	39,848	47,680
Cash paid, net during the period for:	'	'
Interest	3,846	2,256
Income taxes	$15,000	$9,679

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Mar. 31, 2014
Basis of Presentation	'
Basis of Presentation	'
	1. Basis of Presentation
	Description of Business
	OSI Systems, Inc., together with its subsidiaries (the “Company”), is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications and provider of security screening services. The Company sells its products and services in diversified markets, including homeland security, healthcare, defense and aerospace.
	The Company has three reporting segments: (i) Security, providing security inspection systems, turnkey security screening solutions and related services; (ii) Healthcare, providing patient monitoring, diagnostic cardiology and anesthesia systems, and related services and (iii) Optoelectronics and Manufacturing, providing specialized electronic components and electronic manufacturing services for the Security and Healthcare divisions as well as to external original equipment manufacturing clients for applications in the defense, aerospace, medical and industrial markets, among others.
	Through its Security division, the Company designs, manufactures and markets security inspections systems and security screening, threat detection and non-intrusive inspection products and related services globally. These products fall into the following categories: baggage and parcel inspection systems; cargo and vehicle inspection systems; hold (checked) baggage screening systems; people screening systems and radiation detection systems. In addition to these products, the Company provides site design, installation, training and technical support services to its customers. The Company also provides turnkey security screening solutions, which can include the construction, staffing and long term operation of security screening checkpoints for its customers.
	Through its Healthcare division, the Company designs, manufactures and markets patient monitoring, diagnostic cardiology and anesthesia delivery and ventilation systems, and related services worldwide. These products are used by care providers in critical care, emergency and perioperative areas within hospitals as well as physicians’ offices, medical clinics and ambulatory surgery centers.
	Through its Optoelectronics and Manufacturing division, the Company designs, manufactures and markets optoelectronic devices and provides electronics manufacturing services worldwide for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostic products, telecommunications, test and measurement devices, industrial automation systems, automotive diagnostic products and consumer products. This division provides products and services to original equipment manufacturers and end users as well as to the Company’s own Security and Healthcare divisions.
	Basis of Presentation
	The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to interim financial reporting guidelines. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company’s management, the condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented. These condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013. The results of operations for the three and nine months ended March 31, 2014 are not necessarily indicative of the operating results to be expected for the full 2014 fiscal year or any future periods.
	Per Share Computations
	The Company computes basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. The Company computes diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common and dilutive potential common shares outstanding. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock awards or units under the treasury stock method.  Stock awards to purchase 0.1 million shares of common stock for the three and nine months ended March 31, 2014 were excluded from the calculation of diluted earnings per share because to do so would have been antidilutive; while during the three and nine months ended March 31, 2013 no stock awards were excluded from the calculation.
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2014		2013		2014
	Net income available to common stockholders	$	13,529	$	4,801	$	32,289	$	25,768
	Weighted average shares outstanding for basic earnings per share calculation	19,987		19,936		19,964		19,956
	Dilutive effect of stock awards	568		612		614		629
	Weighted average shares outstanding for diluted earnings per share calculation	20,555		20,548		20,578		20,585
	Basic net income per share	$	0.68	$	0.24	$	1.62	$	1.29
	Diluted net income per share	$	0.66	$	0.23	$	1.57	$	1.25
	Cash Equivalents
	The Company considers all highly liquid investments purchased with maturities of approximately three months or less as of the acquisition date to be cash equivalents.
	Fair Value of Financial Instruments
	The Company’s financial instruments consist primarily of cash, marketable securities, derivative instruments, accounts receivable, accounts payable and debt instruments. The carrying values of financial instruments, other than long-term debt instruments, are representative of their fair values due to their short-term maturities. The carrying values of the Company’s long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates offered to the Company.
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. “Level 1” category includes assets and liabilities at the quoted prices in active markets for identical assets and liabilities.  “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. “Level 3” category includes assets and liabilities whose valuation techniques are unobservable and significant to the fair value measurement.  There were no assets or liabilities where “Level 3” valuation techniques were used, and there were no assets and liabilities measured at fair value on a non-recurring basis.
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		March 31,
						2013						2014
	Equity securities	316		—		316		555		—		555
	Insurance company contracts	—		13,914		13,914		—		16,716		16,716
	Interest rate contract	—		66		66		—		58		58
	Total	$	316	$	13,980	$	14,296	$	555	$	16,774	$	17,329
	Derivative Instruments and Hedging Activity
	The Company’s use of derivatives consists of an interest rate swap agreement.  The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to variable, LIBOR-based debt for the duration of the term loan.  The interest rate swap matures in October 2019.  The interest rate swap is considered an effective cash flow hedge, and, as a result, the net gains or losses on such instrument were reported as a component of Other comprehensive income in the condensed consolidated financial statements and are reclassified as net income when the hedge transaction settles.
	Revenue Recognition
	The Company recognizes revenue from sales of products upon shipment when title and risk of loss passes, and when terms are fixed and collection is probable. Revenue from services includes after-market services, installation and implementation of products, and turnkey security screening services. The portion of revenue for the sale attributable to installation is deferred and recognized when the installation service is provided. In an instance where terms of sale include subjective customer acceptance criteria, revenue is deferred until the Company has achieved the acceptance criteria. Concurrent with the shipment of the product, the Company accrues estimated product return reserves and warranty expenses. Critical judgments made by management related to revenue recognition include the determination of whether or not customer acceptance criteria are perfunctory or inconsequential. The determination of whether or not customer acceptance terms are perfunctory or inconsequential impacts the amount and timing of revenue recognized. Critical judgments also include estimates of warranty reserves, which are established based on historical experience and knowledge of the product under warranty.
	Revenue from turnkey services agreements is included in revenue from services. In certain agreements, revenue is recognized based upon proportional performance, measured by the actual number of hours incurred divided by the total estimated number of hours for the project. The impact of changes in the estimated hours to service the agreement is reflected in the period during which the change becomes known.
	Revenues from out of warranty service maintenance contracts are recognized ratably over the term of such contract. For services not derived from specific maintenance contracts, revenues are recognized as the services are performed. Deferred revenue for such services arises from payments received from customers for services not yet performed. On occasion, the Company receives advances from customers that are amortized against future customer payments pursuant to the underlying agreements. Such advances are classified in the condensed consolidated balance sheets as either a current or long term liability dependent upon when the Company estimates the corresponding amortization to occur.
	Business Combinations
	During the normal course of business the Company makes acquisitions.  In the event that an individual acquisition (or an aggregate of acquisitions) is material, appropriate disclosure of such acquisition activity is disclosed.  During the nine months ended March 31, 2014, the Company completed acquisitions that were immaterial both individually and in the aggregate.
	Reclassifications
	We have reclassified certain prior period amounts within our condensed consolidated financial statements to conform to our current year presentation.

Balance_Sheet_Details

Balance Sheet Details	9 Months Ended
	Mar. 31, 2014
Balance Sheet Details	'
Balance Sheet Details	'
	2. Balance Sheet Details
	The following tables provide details of selected balance sheet accounts (in thousands):
		June 30,			March 31,
		2013			2014
	Accounts receivable
	Billed receivables	$	179,458		$	146,622
	Unbilled receivables	34,636			2,664
	Less allowance for doubtful accounts	(7,277		)	(6,480		)
	Total	$	206,817		$	142,806
	Unbilled receivables included earned but unbilled revenue.
		June 30,			March 31,
		2013			2014
	Inventories
	Raw materials	$	117,416		$	122,633
	Work-in-process	37,337			53,014
	Finished goods	51,460			63,379
	Total	$	206,213		$	239,026
		June 30,			March 31,
		2013			2014
	Property and equipment
	Land	$	8,365		$	13,651
	Buildings and improvements	102,187			161,310
	Leasehold improvements	9,302			10,311
	Equipment and tooling	135,437			154,799
	Furniture and fixtures	3,551			4,103
	Computer equipment	14,309			16,970
	Computer software	15,209			15,416
	Construction in process	48,713			11,996
	Total	337,073			388,556
	Less: accumulated depreciation and amortization	(88,044		)	(122,817		)
	Property and equipment, net	$	249,029		$	265,739
	Depreciation expense was approximately $14.4 million and $36.5 million for the nine months ended March 31, 2013 and 2014, respectively, and approximately $5.8 million and $12.6 million for the three months ended March 31, 2013 and 2014, respectively.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	9 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets	'
Goodwill and Intangible Assets	'
	3. Goodwill and Intangible Assets
	The changes in the carrying value of goodwill for the nine month period ended March 31, 2014 are as follows (in thousands):
		Security		Healthcare		Optoelectronics		Consolidated
						and
						Manufacturing
	Balance as of June 30, 2013	$	28,546	$	35,827	$	19,370	$	83,743
	Goodwill acquired or adjusted during the period	784		1,018		5,531		7,333
	Foreign currency translation adjustment	222		299		599		1,120
	Balance as of March 31, 2014	$	29,552	$	37,144	$	25,500	$	92,196
	Intangible assets consisted of the following (in thousands):
				June 30, 2013						March 31, 2014
		Weighted		Gross		Accumulated		Intangibles		Gross		Accumulated		Intangibles
		Average		Carrying		Amortization		Net		Carrying		Amortization		Net
		Lives		Value						Value
	Amortizable assets:
	Software development costs	7 years		$	17,350	$	5,396	$	11,954	$	19,764	$	6,473	$	13,291
	Patents	13 years		5,400		635		4,765		6,320		732		5,588
	Core technology	10 years		2,058		1,728		330		2,235		2,043		192
	Developed technology	11 years		20,002		14,620		5,382		16,360		11,347		5,013
	Customer relationships/ backlog	7 years		9,178		5,624		3,554		11,370		6,718		4,652
	Total amortizable assets			53,988		28,003		25,985		56,049		27,313		28,736
	Non-amortizable assets - Trademarks			10,618		—		10,618		11,989		—		11,989
	Total intangible assets			$	64,606	$	28,003	$	36,603	$	68,038	$	27,313	$	40,725
	Amortization expense related to intangibles assets was $3.5 million for each of the nine months ended March 31, 2013 and 2014, respectively. For the three months ended March 31, 2013 and 2014, amortization expense was $1.2 million and $1.0 million, respectively. At March 31, 2014, the estimated future amortization expense was as follows (in thousands):
	Fiscal Years
	2014 (remaining 3 months)	$	820
	2015	2,911
	2016	3,150
	2017	2,782
	2018	2,633
	2019	2,532
	2020 and thereafter, including assets that have not yet begun to be amortized	13,908
	Total	$	28,736
	Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product by product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in thereafter in the table above. The Company capitalized software development costs in the amount of $2.9 million and $2.2 million for the nine months ended March 31, 2013 and 2014, respectively, and $1.2 million and $0.5 million for each of the three months ended March 31, 2013 and 2014, respectively.

Borrowings

Borrowings	9 Months Ended
	Mar. 31, 2014
Borrowings	'
Borrowings	'
	4. Borrowings
	The Company has a $425 million credit agreement maturing November 2016. The credit agreement consists of a $425 million revolving credit facility, including a $375 million sub-limit for letters of credit. The Company has the ability to increase the facility by $100 million under certain circumstances. Borrowings under this facility bear interest at the London Interbank Offered Rate (LIBOR) plus a margin of 1.5% as of March 31, 2014. This margin is determined by the Company’s consolidated leverage ratio and may range from 1.5% to 2.0%. Letters of credit reduce the amount available to borrow by their face value. The unused portion of the facility bears a commitment fee of 0.25%. The Company’s borrowings under the credit agreement are guaranteed by the Company’s U.S.-based subsidiaries and are secured by substantially all of the Company’s and certain subsidiaries’ assets. The agreement contains various representations and warranties, affirmative and negative and financial covenants, and events of default customary for financing agreements of this type. As of March 31, 2014, there was $22.0 million outstanding under the revolving credit facility and $112.0 million outstanding under the letters-of-credit sub-facility.
	Several of the Company’s foreign subsidiaries maintain bank lines-of-credit, denominated in local currencies, to meet short-term working capital requirements and for the issuance of letters-of-credit. As of March 31, 2014, $5.8 million was outstanding under these letter-of-credit facilities, while no debt was outstanding. As of March 31, 2014, the total amount available under these credit facilities was $35.8 million, with a total cash borrowing sub-limit of $3.2 million.
	In September 2012, the Company entered into a term loan agreement for $11.1 million to fund the acquisition of land and a building in the state of Washington.  The loan, which bears interest at LIBOR plus 1.25%, is payable on a monthly basis over seven years.  Concurrent with entering into the floating rate loan, the Company entered into an interest rate swap agreement that effectively locks the interest rate of the loan to 2.2% per annum for the term of the loan.
	Long-term debt consisted of the following (in thousands):
		June 30,		March 31,
		2013		2014
	Term loans	$	12,470	$	11,316
	Other long-term debt	—		2,310
		12,470		13,626
	Less current portion of long-term debt	1,797		2,779
	Long-term portion of debt	$	10,673	$	10,847

Impairment_Restructuring_and_O

Impairment, Restructuring and Other Charges	9 Months Ended
	Mar. 31, 2014
Impairment, Restructuring and Other Charges	'
Impairment, Restructuring and Other Charges	'
	5.  Impairment, Restructuring and Other Charges
	The following table summarizes the impairment, restructuring and other charges (in thousands):
		Security		Healthcare		Optoelectronics		Corporate	Consolidated
		Division		Division		and
						Manufacturing
						Division
	Balance as of June 30, 2013	$	1,043	$	1,639	$	66	—	$	2,748
	Expensed during the period:
	Facility closures (1)	—		2,009		763		—	2,772
	Employee termination costs (2)	822		—		669		—	1,491
	Charges related to government contract issues (3)	4,298		—		—		—	4,298
	Charges related to class action litigation	—		—		—		364	364
	Total expensed during the period	5,120		2,009		1,432		364	8,925
	Paid or incurred during the period	4,546		2,046		1,215		364	8,171
	Balance as of March 31, 2014	$	1,617	$	1,602	$	283	—	$	3,502
	(1)         The facility relocation within the Healthcare division began in fiscal 2013 and was completed during the first quarter of fiscal 2014.  The facility consolidations within the Optoelectronics and Manufacturing division began during the first quarter of fiscal 2014 and are expected to be completed during the remainder of the year.
	(2)         The employee termination costs within the Security division were incurred as a result of management restructuring. The employee termination costs within the Optoelectronics and Manufacturing division related to facility consolidations that began in the first quarter of fiscal 2014 and are expected to be completed during the remainder of the fiscal year.
	(3)         These costs related to a contract with the Transportation Security Administration (TSA) terminated in fiscal 2013 and current contract issues with the TSA and other U.S. government agencies.  These costs include removal, storage and refurbishing costs for products previously sold to the TSA as required by the termination, and legal and other costs for the current contract issues.

Stockbased_Compensation

Stock-based Compensation	9 Months Ended
	Mar. 31, 2014
Stock-based Compensation	'
Stock-based Compensation	'
	6. Stock-based Compensation
	As of March 31, 2014, the Company maintained two share-based employee compensation plans (the “OSI Plans”): the 2012 Incentive Award Plan (“2012 Plan”) and the 2006 Equity Participation Plan (“2006 Plan”).  Upon the effective date of the 2012 Plan, the Company ceased to make grants under the 2006 Plan.
	The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Cost of goods sold	$	335		$	180		$	601		$	705
	Selling, general and administrative	3,944			3,057			10,709			13,130
	Research and development	57			17			172			140
	Stock-based compensation expense before taxes	$	4,336		$	3,254		11,482			$	13,975
	Less: related income tax benefit	1,656			1,319			4,364			5,457
	Stock-based compensation expense, net of estimated taxes	$	2,680		$	1,935		$	7,118		$	8,518
	As of March 31, 2014, total unrecognized compensation cost related to share-based compensation grants were estimated at $1.3 million for stock options and $18.7 million for restricted stock and restricted stock units (“RSUs”) under the OSI Plans.  The Company expects to recognize these costs over a weighted-average period of 1.6 years with respect to the options and 2.0 years for grants of restricted stock and RSUs.
	The following summarizes stock option activity during the nine months ended March 31, 2014:
		Number of		Weighted-			Weighted-Average		Aggregate
		Options		Average			Remaining Contractual		Intrinsic Value
				Exercise			Term		(in thousands)
				Price
	Outstanding at June 30, 2013	1,019,733		$	26.33
	Granted	10,294		$	70.59
	Exercised	(1,169	)	$	39.97
	Expired or forfeited	(4,646	)	$	54.07
	Outstanding at March 31, 2014	1,024,212		$	26.63		5.9 years		$	34,144
	Exercisable at March 31, 2014	845,805		$	22.55		5.4 years		$	31,537
	A summary of restricted stock and RSU award activity during the nine months ended March 31, 2014 is as follows:
		Shares		Weighted-
				Average
				Fair Value
	Nonvested at June 30, 2013	627,124		$	43.19
	Granted	322,275		63.73
	Vested	(276,716	)	39.16
	Forfeited	(3,992	)	49.23
	Nonvested at March 31, 2014	668,691		$	54.73
	As of March 31, 2014, there were 3,322,921 shares available for grant under the 2012 Plan.  Under the terms of that plan, restricted stock and RSUs granted from the pool of shares available for grant on or after December 12, 2012 reduce the pool by 1.87 shares for each share granted.  Restricted stock and RSUs forfeited and returned to the pool of shares available for grant increase the pool by 1.87 shares for each share forfeited.
	The Company granted 178,500 and 160,922 performance-based awards during the nine months ended March 31, 2013 and 2014 respectively. These performance-based restricted stock and RSU awards are contingent on the achievement of certain financial performance metrics. The payout can range from zero to 250% of the original number of shares or units awarded, which are converted into shares of the Company’s common stock.

Retirement_Benefit_Plans

Retirement Benefit Plans	9 Months Ended
	Mar. 31, 2014
Retirement Benefit Plans	'
Retirement Benefit Plans	'
	7. Retirement Benefit Plans
	The Company sponsors various retirement benefit plans including qualified and nonqualified defined benefit pension plans for its employees. The components of net periodic pension expense are as follows (in thousands):
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2014		2013		2014
	Service cost	$	269	$	288	$	853	$	890
	Amortization of prior service cost	229		202		689		606
	Net periodic pension expense	$	498	$	490	$	1,542	$	1,496
	For each of the three months ended March 31, 2013 and 2014, the Company made contributions of $0.1 million to these defined benefit plans. For the nine months ended March 31, 2013 and 2014, the Company made contributions of $0.1 million and $1.0 million, respectively, to these defined benefit plans.
	In addition, the Company maintains various defined contribution plans. For the three months ended March 31, 2013 and 2014, the Company made contributions of $0.9 and $1.0 million, respectively, to these defined contribution plans. For the nine months ended March 31, 2013 and 2014, the Company made contributions of $2.7 million and $3.0 million, respectively, to these defined contribution plans.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2014
Commitments and Contingencies	'
Commitments and Contingencies	'
	8. Commitments and Contingencies
	Legal Proceedings
	On December 12, 2013, a putative class action complaint was filed against the Company and certain of its officers in the United States District Court for the Central District of California (“Court”), captioned Roberti v. OSI Systems, Inc., et al., Case No. 2:13-cv-09174-MWF-VBK (the “Roberti Action”).  The Roberti Action purports to be brought on behalf of persons who purchased the Company’s common stock between January 24, 2012 and December 6, 2013.  The complaint generally asserts that defendants violated section 10(b) of the Securities Exchange Act of 1934 (the “Act”) and Rule 10b-5 promulgated thereunder and also that the individual defendants violated section 20(a) of the Act by misrepresenting or failing to disclose that the Company allegedly manipulated operational testing of its Advanced Imaging Technology by selectively picking the best sensors and thereby causing the testing not to be representative of the scanners already deployed at airports; that certain of the Company’s products allegedly raised strong privacy concerns and were subject to disqualification for use in airport security checkpoints; and that the Company allegedly manufactured its products with parts that violated contracts with TSA, thereby risking cancellation of the contracts.  Plaintiffs demand a jury trial and seek class certification, unspecified damages, an award of pre-judgment and post-judgment interest, attorneys’ and experts’ fees, costs, and other unspecified relief.  On March 17, 2014, the Court appointed plaintiff Arkansas State Highway Employees Retirement System as lead plaintiff.
	On April 15, 2014, a putative shareholder derivative complaint was filed in the Court against the Company (as nominal defendant) and the members of the Company’s Board of Directors (as individual defendants) as a related case to the Roberti Action and was captioned Hagan v. Chopra, et al., Case No. 2:14-cv-02910-ODW-PJW (the “Derivative Action”).  The complaint in the Derivative Action generally asserts the same factual allegations as those at issue in the Roberti Action and also claims that certain of the individual defendants allegedly sold stock based on material non-public information.  The plaintiff in the Derivative Action asserts that, while he never made any demand on the Board of Directors to take corrective action, demand was purportedly excused.  The Derivative Action generally brings claims for breach of fiduciary duties and unjust enrichment, and the complaint seeks unspecified damages, restitution, injunctive relief, attorneys’ and experts’ fees, costs, expenses, and other unspecified relief.
	While the Company believes that the Roberti Action and the Derivative Action are without merit and intends to defend the litigation vigorously, it expects to incur costs associated with defending the Roberti Action and the Derivative Action. At this early stage of the litigations, the ultimate outcomes of the Roberti Action and the Derivative Action are uncertain and the Company cannot reasonably assess the timing or outcomes, or estimate the amount of loss, if any, or their effect, if any, on its financial statements.
	The Company is involved in various other claims and legal proceedings arising in the ordinary course of business. In the Company’s opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on its business, financial condition, results of operations or cash flows.  The Company has not accrued for loss contingencies relating to such matters because the Company believes that, although unfavorable outcomes in the proceedings may be possible, they are not considered by management to be probable or reasonably estimable. If one or more of these matters are resolved in a manner adverse to the Company, the impact on the Company’s business, financial condition, results of operations and/or liquidity could be material.
	Contingent Acquisition Obligations
	Under the terms and conditions of the purchase agreements associated with certain acquisitions, the Company may be obligated to make additional payments based on the achievement by the acquired operations of certain sales or profitability milestones. The maximum amount of such future payments under arrangements with contingent consideration caps is $51 million as of March 31, 2014. In addition, one of the purchase agreements the Company entered into requires royalty payments through 2022 based on the license of, or sales of products containing, the technology of CXR Limited, a company acquired in 2004. For acquisitions that occurred prior to fiscal year 2010, the Company accounts for such contingent payments as an addition to the purchase price of the acquired business. Otherwise, the estimated fair value of these obligations is recorded as a liability at the time of the acquisition in the condensed consolidated balance sheets with subsequent revisions reflected in the condensed consolidated statements of operations. As of June 30, 2013 and March 31, 2014, $15.4 million and $18.5 million of contingent payment obligations, respectively, are included in Other long-term liabilities in the accompanying condensed consolidated balance sheets.
	Advances from Customers
	The Company receives advances from customers associated with certain projects.  In fiscal 2012, the Company entered into an agreement with the Mexican government to provide a turnkey security screening solution along the country’s borders, and in its ports and airports.  Associated with the agreement, the Company was provided an advance totaling $100 million.  The Company is obligated to provide a guarantee until the advance has been amortized.  As of March 31, 2014, $81.3 million of this advance remains outstanding.
	Environmental Contingencies
	The Company is subject to various environmental laws. The Company’s practice is to conduct appropriate environmental investigations for each of its properties in the United States at which the Company manufactures products in order to identify, as of the date of such report, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, the Company has conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.
	During one investigation, the Company discovered soil and groundwater contamination at its Hawthorne, California facility that the Company believes was the result of unspecified on- and off-site releases occurring prior to the Company’s occupancy. Historical usage of this site includes semiconductor and electronics manufacturing, dating back to the mid-1960’s, as well as possible aircraft and related manufacturing dating to the early 1940’s. Similar operations, including chemical manufacturing and storage, were conducted at neighboring sites throughout that period and into the 1990’s.  It is not presently known when the releases occurred or by whom they were caused, though Company records, in conjunction with data obtained from soil and groundwater surveys, support the Company’s assertion that these releases are historical in nature. Further, the groundwater contamination is a known regional issue, not limited to the Company’s premises or its immediate surroundings. The Company filed the requisite reports concerning this site with the appropriate environmental authorities upon discovery, and in cooperation with the local governing agency has provided additional historical information and conducted further site characterization studies.  Recent soil and groundwater investigations, including the installation of groundwater monitoring wells, were completed in fiscal 2014. Results from these studies are being evaluated to determine the extent of the on-site releases and whether any soils remediation will be required. Periodic groundwater monitoring is expected to continue until such time as the governing authority requests further action.
	The Company has not accrued for loss contingencies relating to the Hawthorne facility or any other environmental matters because it believes that, although unfavorable outcomes may be possible, they are not considered by the Company’s management to be probable and reasonably estimable. If one or more of environmental matters are resolved in a manner adverse to the Company, the impact on the Company’s business, financial condition, results of operations, financial position and/or liquidity could be material.
	Indemnifications
	In the normal course of business, the Company has agreed to indemnify certain parties with respect to certain matters. The Company has agreed to hold certain parties harmless against losses arising from a breach of representations, warranties or covenants, or out of intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. The Company has not recorded any liability for costs related to indemnification as of March 31, 2014.
	Other Matters
	On December 5, 2013, the Company’s Security division was notified by the TSA that a delivery order that it had received on September 26, 2013, for baggage and handling inspection systems was being terminated for default.  The termination resulted from the use of an upgraded X-ray generator component. While the component had been vetted by the Security division’s internal quality assurance, the Security division had not met the contractual requirement of obtaining the TSA’s approval in advance.  As a result of this termination for default, the Security division has been referred to the U.S. Department of Homeland Security for further review.  Although the results of this review cannot be determined at this time, among other consequences, the Security division could be barred from conducting future business with the U.S. federal government for a period of time.
	Product Warranties
	The Company offers its customers warranties on many of the products that it sells. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, the Company records a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. The Company periodically adjusts this provision based on historical experience and anticipated expenses. The Company charges actual expenses of repairs under warranty, including parts and labor, to this provision when incurred.
	The following table presents changes in warranty provisions (in thousands):
		Nine Months Ended
		March 31,
		2013			2014
	Balance at beginning of period	$	17,562		$	12,890
	Warrantee claims provision	1,195			3,306
	Settlements made	(4,794		)	(4,840		)
	Balance at end of period	13,963			$	11,356

Income_Taxes

Income Taxes	9 Months Ended
	Mar. 31, 2014
Income Taxes	'
Income Taxes	'
	9. Income Taxes
	The provision for income taxes is determined using an effective tax rate that is subject to fluctuations during the year as new information is obtained.  The assumptions used to estimate the annual effective tax rate include factors such as the mix of pre-tax earnings in the various tax jurisdictions in which the Company operates, valuation allowances against deferred tax assets, increases or decreases in uncertain tax positions, utilization of research and development tax credits, changes in or the interpretation of tax laws in jurisdictions where the Company conducts business and certain tax elections. During the three months ended March 31, 2014, the Company elected to accelerate depreciation of certain foreign assets. As a result of this election the tax bases of these assets were permanently reduced, which increased the effective tax rate for the three months and nine months ended March 31, 2014 to 71.2% and 44.2%, respectively.  Had this election not been made and the assets were depreciated using regular depreciation, the effective tax rate would have been 25.3% and 27.7% for the three and nine months ended March 31, 2014, respectively.  Effective for tax years beginning January 1, 2014, the election to accelerate depreciation is no longer available in the Mexican tax code.  The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of its assets and liabilities along with net operating loss and tax credit carryovers. The Company records a valuation allowance against its deferred tax assets to reduce the net carrying value to an amount that it believes is more likely than not to be realized. When the Company establishes or reduces the valuation allowance against its deferred tax assets, the provision for income taxes will increase or decrease, respectively, in the period such determination is made.

Segment_Information

Segment Information	9 Months Ended
	Mar. 31, 2014
Segment Information	'
Segment Information	'
	10. Segment Information
	The Company has determined that it operates in three identifiable industry segments, (a) security and inspection systems (Security division), (b) medical monitoring and anesthesia systems (Healthcare division) and (c) optoelectronic devices and manufacturing (Optoelectronics and Manufacturing division). The Company also has a corporate segment (Corporate) that includes executive compensation and certain other general and administrative expenses, expenses related to stock issuances and legal and audit and other professional service fees not allocated to product segments. Both the Security and Healthcare divisions comprise primarily end-user businesses, while the Optoelectronics and Manufacturing division primarily supplies components and subsystems to original equipment manufacturers, including to the Security and Healthcare divisions. Sales between divisions are at transfer prices that approximate market values.  All other accounting policies of the segments are the same as described in Note 1, Summary of Significant Accounting Policies of the Form 10-K for the fiscal year ended June 30, 2013.
	The following tables present the operations and identifiable assets by industry segment (in thousands):
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Revenues (2) — by Segment:
	Security division	$	99,840		$	95,007		$	274,619		$	298,748
	Healthcare division	51,357			52,188			159,052			161,081
	Optoelectronics and Manufacturing division, including intersegment revenues	54,761			66,331			169,185			214,000
	Intersegment revenues elimination	(7,549		)	(9,570		)	(28,704		)	(27,191		)
	Total	$	198,409		$	203,956		$	574,152		$	646,638
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Operating income (loss) — by Segment:
	Security division	$	16,179		$	14,213		$	29,251		$	40,984
	Healthcare division	3,593			4,084			14,389			11,312
	Optoelectronics and Manufacturing division	3,271			3,414			13,561			10,300
	Corporate	(4,017		)	(3,488		)	(9,704		)	(11,888		)
	Eliminations (1)	388			(201		)	709			(184		)
	Total	$	19,414		$	18,022		$	48,206		$	50,524
		June 30,			March 31,
		2013			2014
	Assets — by Segment:
	Security division	$	499,539		$	505,334
	Healthcare division	190,963			172,136
	Optoelectronics and Manufacturing division	158,584			178,421
	Corporate	75,496			88,825
	Eliminations (1)	(4,786		)	(4,969		)
	Total	$	919,796		$	939,747
	(1)         Eliminations within operating income primarily reflect the change in the elimination of intercompany profit in inventory not-yet-realized. Eliminations in assets reflect the amount of intercompany profits in inventory as of the balance sheet date. Such intercompany profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.
	(2)         One customer accounted for 16% and 15% of total net revenues for the three and nine months ended March 31, 2014, respectively; and the same customer accounted for 14% and 8% of total net revenues for the three and nine months ended March 31, 2013, respectively. No customers accounted for 10% or more of receivables as of March 31, 2014.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	9 Months Ended
	Mar. 31, 2014
Basis of Presentation	'
Description of Business	'
	Description of Business
	OSI Systems, Inc., together with its subsidiaries (the “Company”), is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications and provider of security screening services. The Company sells its products and services in diversified markets, including homeland security, healthcare, defense and aerospace.
	The Company has three reporting segments: (i) Security, providing security inspection systems, turnkey security screening solutions and related services; (ii) Healthcare, providing patient monitoring, diagnostic cardiology and anesthesia systems, and related services and (iii) Optoelectronics and Manufacturing, providing specialized electronic components and electronic manufacturing services for the Security and Healthcare divisions as well as to external original equipment manufacturing clients for applications in the defense, aerospace, medical and industrial markets, among others.
	Through its Security division, the Company designs, manufactures and markets security inspections systems and security screening, threat detection and non-intrusive inspection products and related services globally. These products fall into the following categories: baggage and parcel inspection systems; cargo and vehicle inspection systems; hold (checked) baggage screening systems; people screening systems and radiation detection systems. In addition to these products, the Company provides site design, installation, training and technical support services to its customers. The Company also provides turnkey security screening solutions, which can include the construction, staffing and long term operation of security screening checkpoints for its customers.
	Through its Healthcare division, the Company designs, manufactures and markets patient monitoring, diagnostic cardiology and anesthesia delivery and ventilation systems, and related services worldwide. These products are used by care providers in critical care, emergency and perioperative areas within hospitals as well as physicians’ offices, medical clinics and ambulatory surgery centers.
	Through its Optoelectronics and Manufacturing division, the Company designs, manufactures and markets optoelectronic devices and provides electronics manufacturing services worldwide for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostic products, telecommunications, test and measurement devices, industrial automation systems, automotive diagnostic products and consumer products. This division provides products and services to original equipment manufacturers and end users as well as to the Company’s own Security and Healthcare divisions.
Basis of Presentation	'
	Basis of Presentation
	The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to interim financial reporting guidelines. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company’s management, the condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented. These condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013. The results of operations for the three and nine months ended March 31, 2014 are not necessarily indicative of the operating results to be expected for the full 2014 fiscal year or any future periods.
Per Share Computations	'
	Per Share Computations
	The Company computes basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. The Company computes diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common and dilutive potential common shares outstanding. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock awards or units under the treasury stock method.  Stock awards to purchase 0.1 million shares of common stock for the three and nine months ended March 31, 2014 were excluded from the calculation of diluted earnings per share because to do so would have been antidilutive; while during the three and nine months ended March 31, 2013 no stock awards were excluded from the calculation.
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2014		2013		2014
	Net income available to common stockholders	$	13,529	$	4,801	$	32,289	$	25,768
	Weighted average shares outstanding for basic earnings per share calculation	19,987		19,936		19,964		19,956
	Dilutive effect of stock awards	568		612		614		629
	Weighted average shares outstanding for diluted earnings per share calculation	20,555		20,548		20,578		20,585
	Basic net income per share	$	0.68	$	0.24	$	1.62	$	1.29
	Diluted net income per share	$	0.66	$	0.23	$	1.57	$	1.25
Cash Equivalents	'
	Cash Equivalents
	The Company considers all highly liquid investments purchased with maturities of approximately three months or less as of the acquisition date to be cash equivalents.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company’s financial instruments consist primarily of cash, marketable securities, derivative instruments, accounts receivable, accounts payable and debt instruments. The carrying values of financial instruments, other than long-term debt instruments, are representative of their fair values due to their short-term maturities. The carrying values of the Company’s long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates offered to the Company.
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. “Level 1” category includes assets and liabilities at the quoted prices in active markets for identical assets and liabilities.  “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. “Level 3” category includes assets and liabilities whose valuation techniques are unobservable and significant to the fair value measurement.  There were no assets or liabilities where “Level 3” valuation techniques were used, and there were no assets and liabilities measured at fair value on a non-recurring basis.
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		March 31,
						2013						2014
	Equity securities	316		—		316		555		—		555
	Insurance company contracts	—		13,914		13,914		—		16,716		16,716
	Interest rate contract	—		66		66		—		58		58
	Total	$	316	$	13,980	$	14,296	$	555	$	16,774	$	17,329
Derivative Instruments and Hedging Activity	'
	Derivative Instruments and Hedging Activity
	The Company’s use of derivatives consists of an interest rate swap agreement.  The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to variable, LIBOR-based debt for the duration of the term loan.  The interest rate swap matures in October 2019.  The interest rate swap is considered an effective cash flow hedge, and, as a result, the net gains or losses on such instrument were reported as a component of Other comprehensive income in the condensed consolidated financial statements and are reclassified as net income when the hedge transaction settles.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue from sales of products upon shipment when title and risk of loss passes, and when terms are fixed and collection is probable. Revenue from services includes after-market services, installation and implementation of products, and turnkey security screening services. The portion of revenue for the sale attributable to installation is deferred and recognized when the installation service is provided. In an instance where terms of sale include subjective customer acceptance criteria, revenue is deferred until the Company has achieved the acceptance criteria. Concurrent with the shipment of the product, the Company accrues estimated product return reserves and warranty expenses. Critical judgments made by management related to revenue recognition include the determination of whether or not customer acceptance criteria are perfunctory or inconsequential. The determination of whether or not customer acceptance terms are perfunctory or inconsequential impacts the amount and timing of revenue recognized. Critical judgments also include estimates of warranty reserves, which are established based on historical experience and knowledge of the product under warranty.
	Revenue from turnkey services agreements is included in revenue from services. In certain agreements, revenue is recognized based upon proportional performance, measured by the actual number of hours incurred divided by the total estimated number of hours for the project. The impact of changes in the estimated hours to service the agreement is reflected in the period during which the change becomes known.
	Revenues from out of warranty service maintenance contracts are recognized ratably over the term of such contract. For services not derived from specific maintenance contracts, revenues are recognized as the services are performed. Deferred revenue for such services arises from payments received from customers for services not yet performed. On occasion, the Company receives advances from customers that are amortized against future customer payments pursuant to the underlying agreements. Such advances are classified in the condensed consolidated balance sheets as either a current or long term liability dependent upon when the Company estimates the corresponding amortization to occur.
Business Combinations	'
	Business Combinations
	During the normal course of business the Company makes acquisitions.  In the event that an individual acquisition (or an aggregate of acquisitions) is material, appropriate disclosure of such acquisition activity is disclosed.  During the nine months ended March 31, 2014, the Company completed acquisitions that were immaterial both individually and in the aggregate.
Reclassifications	'
	Reclassifications
	We have reclassified certain prior period amounts within our condensed consolidated financial statements to conform to our current year presentation.

Basis_of_Presentation_Tables

Basis of Presentation (Tables)	9 Months Ended
	Mar. 31, 2014
Basis of Presentation	'
Schedule of computation of basic and diluted earnings per share	'
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2014		2013		2014
	Net income available to common stockholders	$	13,529	$	4,801	$	32,289	$	25,768
	Weighted average shares outstanding for basic earnings per share calculation	19,987		19,936		19,964		19,956
	Dilutive effect of stock awards	568		612		614		629
	Weighted average shares outstanding for diluted earnings per share calculation	20,555		20,548		20,578		20,585
	Basic net income per share	$	0.68	$	0.24	$	1.62	$	1.29
	Diluted net income per share	$	0.66	$	0.23	$	1.57	$	1.25
Summary of the investments carried at fair value	'
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		March 31,
						2013						2014
	Equity securities	316		—		316		555		—		555
	Insurance company contracts	—		13,914		13,914		—		16,716		16,716
	Interest rate contract	—		66		66		—		58		58
	Total	$	316	$	13,980	$	14,296	$	555	$	16,774	$	17,329

Balance_Sheet_Details_Tables

Balance Sheet Details (Tables)	9 Months Ended
	Mar. 31, 2014
Balance Sheet Details	'
Schedule of selected balance sheet accounts	'
	The following tables provide details of selected balance sheet accounts (in thousands):
		June 30,			March 31,
		2013			2014
	Accounts receivable
	Billed receivables	$	179,458		$	146,622
	Unbilled receivables	34,636			2,664
	Less allowance for doubtful accounts	(7,277		)	(6,480		)
	Total	$	206,817		$	142,806
	Unbilled receivables included earned but unbilled revenue.
		June 30,			March 31,
		2013			2014
	Inventories
	Raw materials	$	117,416		$	122,633
	Work-in-process	37,337			53,014
	Finished goods	51,460			63,379
	Total	$	206,213		$	239,026
		June 30,			March 31,
		2013			2014
	Property and equipment
	Land	$	8,365		$	13,651
	Buildings and improvements	102,187			161,310
	Leasehold improvements	9,302			10,311
	Equipment and tooling	135,437			154,799
	Furniture and fixtures	3,551			4,103
	Computer equipment	14,309			16,970
	Computer software	15,209			15,416
	Construction in process	48,713			11,996
	Total	337,073			388,556
	Less: accumulated depreciation and amortization	(88,044		)	(122,817		)
	Property and equipment, net	$	249,029		$	265,739

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets	'
Schedule of carrying amount of goodwill	'
	The changes in the carrying value of goodwill for the nine month period ended March 31, 2014 are as follows (in thousands):
		Security		Healthcare		Optoelectronics		Consolidated
						and
						Manufacturing
	Balance as of June 30, 2013	$	28,546	$	35,827	$	19,370	$	83,743
	Goodwill acquired or adjusted during the period	784		1,018		5,531		7,333
	Foreign currency translation adjustment	222		299		599		1,120
	Balance as of March 31, 2014	$	29,552	$	37,144	$	25,500	$	92,196
Schedule of intangible assets	'
	Intangible assets consisted of the following (in thousands):
				June 30, 2013						March 31, 2014
		Weighted		Gross		Accumulated		Intangibles		Gross		Accumulated		Intangibles
		Average		Carrying		Amortization		Net		Carrying		Amortization		Net
		Lives		Value						Value
	Amortizable assets:
	Software development costs	7 years		$	17,350	$	5,396	$	11,954	$	19,764	$	6,473	$	13,291
	Patents	13 years		5,400		635		4,765		6,320		732		5,588
	Core technology	10 years		2,058		1,728		330		2,235		2,043		192
	Developed technology	11 years		20,002		14,620		5,382		16,360		11,347		5,013
	Customer relationships/ backlog	7 years		9,178		5,624		3,554		11,370		6,718		4,652
	Total amortizable assets			53,988		28,003		25,985		56,049		27,313		28,736
	Non-amortizable assets - Trademarks			10,618		—		10,618		11,989		—		11,989
	Total intangible assets			$	64,606	$	28,003	$	36,603	$	68,038	$	27,313	$	40,725
Schedule of estimated future amortization expense	'
	At March 31, 2014, the estimated future amortization expense was as follows (in thousands):
	Fiscal Years
	2014 (remaining 3 months)	$	820
	2015	2,911
	2016	3,150
	2017	2,782
	2018	2,633
	2019	2,532
	2020 and thereafter, including assets that have not yet begun to be amortized	13,908
	Total	$	28,736

Borrowings_Tables

Borrowings (Tables)	9 Months Ended
	Mar. 31, 2014
Borrowings	'
Schedule of long-term debt	'
	Long-term debt consisted of the following (in thousands):
		June 30,		March 31,
		2013		2014
	Term loans	$	12,470	$	11,316
	Other long-term debt	—		2,310
		12,470		13,626
	Less current portion of long-term debt	1,797		2,779
	Long-term portion of debt	$	10,673	$	10,847

Impairment_Restructuring_and_O1

Impairment, Restructuring and Other Charges (Tables)	9 Months Ended
	Mar. 31, 2014
Impairment, Restructuring and Other Charges	'
Summary of the impairment, restructuring and other charges	'
	The following table summarizes the impairment, restructuring and other charges (in thousands):
		Security		Healthcare		Optoelectronics		Corporate	Consolidated
		Division		Division		and
						Manufacturing
						Division
	Balance as of June 30, 2013	$	1,043	$	1,639	$	66	—	$	2,748
	Expensed during the period:
	Facility closures (1)	—		2,009		763		—	2,772
	Employee termination costs (2)	822		—		669		—	1,491
	Charges related to government contract issues (3)	4,298		—		—		—	4,298
	Charges related to class action litigation	—		—		—		364	364
	Total expensed during the period	5,120		2,009		1,432		364	8,925
	Paid or incurred during the period	4,546		2,046		1,215		364	8,171
	Balance as of March 31, 2014	$	1,617	$	1,602	$	283	—	$	3,502
	(1)         The facility relocation within the Healthcare division began in fiscal 2013 and was completed during the first quarter of fiscal 2014.  The facility consolidations within the Optoelectronics and Manufacturing division began during the first quarter of fiscal 2014 and are expected to be completed during the remainder of the year.
	(2)         The employee termination costs within the Security division were incurred as a result of management restructuring. The employee termination costs within the Optoelectronics and Manufacturing division related to facility consolidations that began in the first quarter of fiscal 2014 and are expected to be completed during the remainder of the fiscal year.
	(3)         These costs related to a contract with the Transportation Security Administration (TSA) terminated in fiscal 2013 and current contract issues with the TSA and other U.S. government agencies.  These costs include removal, storage and refurbishing costs for products previously sold to the TSA as required by the termination, and legal and other costs for the current contract issues.

Stockbased_Compensation_Tables

Stock-based Compensation (Tables)	9 Months Ended
	Mar. 31, 2014
Stock-based Compensation	'
Schedule of stock-based compensation expense recorded in the condensed consolidated statements of operations	'
	The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Cost of goods sold	$	335		$	180		$	601		$	705
	Selling, general and administrative	3,944			3,057			10,709			13,130
	Research and development	57			17			172			140
	Stock-based compensation expense before taxes	$	4,336		$	3,254		11,482			$	13,975
	Less: related income tax benefit	1,656			1,319			4,364			5,457
	Stock-based compensation expense, net of estimated taxes	$	2,680		$	1,935		$	7,118		$	8,518
Summary of stock option activity	'
		Number of		Weighted-			Weighted-Average		Aggregate
		Options		Average			Remaining Contractual		Intrinsic Value
				Exercise			Term		(in thousands)
				Price
	Outstanding at June 30, 2013	1,019,733		$	26.33
	Granted	10,294		$	70.59
	Exercised	(1,169	)	$	39.97
	Expired or forfeited	(4,646	)	$	54.07
	Outstanding at March 31, 2014	1,024,212		$	26.63		5.9 years		$	34,144
	Exercisable at March 31, 2014	845,805		$	22.55		5.4 years		$	31,537
Summary of restricted stock and RSU award activity	'
		Shares		Weighted-
				Average
				Fair Value
	Nonvested at June 30, 2013	627,124		$	43.19
	Granted	322,275		63.73
	Vested	(276,716	)	39.16
	Forfeited	(3,992	)	49.23
	Nonvested at March 31, 2014	668,691		$	54.73

Retirement_Benefit_Plans_Table

Retirement Benefit Plans (Tables)	9 Months Ended
	Mar. 31, 2014
Retirement Benefit Plans	'
Schedule of components of net periodic pension expense	'
	The components of net periodic pension expense are as follows (in thousands):
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2014		2013		2014
	Service cost	$	269	$	288	$	853	$	890
	Amortization of prior service cost	229		202		689		606
	Net periodic pension expense	$	498	$	490	$	1,542	$	1,496

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 31, 2014
Commitments and Contingencies	'
Schedule of changes in warranty provisions	'
	The following table presents changes in warranty provisions (in thousands):
		Nine Months Ended
		March 31,
		2013			2014
	Balance at beginning of period	$	17,562		$	12,890
	Warrantee claims provision	1,195			3,306
	Settlements made	(4,794		)	(4,840		)
	Balance at end of period	13,963			$	11,356

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Mar. 31, 2014
Segment Information	'
Schedule of operations and identifiable assets by industry segment	'
	The following tables present the operations and identifiable assets by industry segment (in thousands):
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Revenues (2) — by Segment:
	Security division	$	99,840		$	95,007		$	274,619		$	298,748
	Healthcare division	51,357			52,188			159,052			161,081
	Optoelectronics and Manufacturing division, including intersegment revenues	54,761			66,331			169,185			214,000
	Intersegment revenues elimination	(7,549		)	(9,570		)	(28,704		)	(27,191		)
	Total	$	198,409		$	203,956		$	574,152		$	646,638
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2013			2014			2013			2014
	Operating income (loss) — by Segment:
	Security division	$	16,179		$	14,213		$	29,251		$	40,984
	Healthcare division	3,593			4,084			14,389			11,312
	Optoelectronics and Manufacturing division	3,271			3,414			13,561			10,300
	Corporate	(4,017		)	(3,488		)	(9,704		)	(11,888		)
	Eliminations (1)	388			(201		)	709			(184		)
	Total	$	19,414		$	18,022		$	48,206		$	50,524
		June 30,			March 31,
		2013			2014
	Assets — by Segment:
	Security division	$	499,539		$	505,334
	Healthcare division	190,963			172,136
	Optoelectronics and Manufacturing division	158,584			178,421
	Corporate	75,496			88,825
	Eliminations (1)	(4,786		)	(4,969		)
	Total	$	919,796		$	939,747
	(1)         Eliminations within operating income primarily reflect the change in the elimination of intercompany profit in inventory not-yet-realized. Eliminations in assets reflect the amount of intercompany profits in inventory as of the balance sheet date. Such intercompany profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.
	(2)         One customer accounted for 16% and 15% of total net revenues for the three and nine months ended March 31, 2014, respectively; and the same customer accounted for 14% and 8% of total net revenues for the three and nine months ended March 31, 2013, respectively. No customers accounted for 10% or more of receivables as of March 31, 2014.

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
			Item
Description of business	'	'	'	'
Number of operating segments	'	'	3	'
Earnings per Share	'	'	'	'
Antidilutive shares associated with stock options or stock awards or units	100,000	0	100,000	0
Computation of basic and diluted earnings per share	'	'	'	'
Net income available to common stockholders	$4,801	$13,529	$25,768	$32,289
Weighted average shares outstanding for basic earnings per share calculation	19,936,000	19,987,000	19,956,000	19,964,000
Dilutive effect of stock awards	612,000	568,000	629,000	614,000
Weighted average shares outstanding for diluted earnings per share calculation	20,548,000	20,555,000	20,585,000	20,578,000
Basic net income per share (in dollars per share)	$0.24	$0.68	$1.29	$1.62
Diluted net income per share (in dollars per share)	$0.23	$0.66	$1.25	$1.57

Basis_of_Presentation_Details_

Basis of Presentation (Details 2) (USD $)	Mar. 31, 2014	Jun. 30, 2013
In Thousands, unless otherwise specified
Level 3	'	'
Fair value of financial instruments	'	'
Fair value of liabilities	$0	$0
Fair value of assets	0	0
Recurring | Level 1	'	'
Fair value of financial instruments	'	'
Total	555	316
Recurring | Level 1 | Equity securities	'	'
Fair value of financial instruments	'	'
Equity securities	555	316
Recurring | Level 2	'	'
Fair value of financial instruments	'	'
Insurance company contracts	16,716	13,914
Interest rate contract	58	66
Total	16,774	13,980
Recurring | Total	'	'
Fair value of financial instruments	'	'
Insurance company contracts	16,716	13,914
Interest rate contract	58	66
Total	17,329	14,296
Recurring | Total | Equity securities	'	'
Fair value of financial instruments	'	'
Equity securities	555	316
Non-recurring	'	'
Fair value of financial instruments	'	'
Fair value of liabilities	0	0
Fair value of assets	$0	$0

Balance_Sheet_Details_Details

Balance Sheet Details (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Accounts receivable	'	'	'	'	'
Billed receivables	$146,622,000	'	$146,622,000	'	$179,458,000
Unbilled receivables	2,664,000	'	2,664,000	'	34,636,000
Less allowance for doubtful accounts	-6,480,000	'	-6,480,000	'	-7,277,000
Total	142,806,000	'	142,806,000	'	206,817,000
Inventories	'	'	'	'	'
Raw materials	122,633,000	'	122,633,000	'	117,416,000
Work-in-process	53,014,000	'	53,014,000	'	37,337,000
Finished goods	63,379,000	'	63,379,000	'	51,460,000
Total	239,026,000	'	239,026,000	'	206,213,000
Property and equipment	'	'	'	'	'
Property and equipment, gross	388,556,000	'	388,556,000	'	337,073,000
Less: accumulated depreciation and amortization	-122,817,000	'	-122,817,000	'	-88,044,000
Property and equipment, net	265,739,000	'	265,739,000	'	249,029,000
Depreciation expense	12,600,000	5,800,000	36,500,000	14,400,000	'
Land	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	13,651,000	'	13,651,000	'	8,365,000
Buildings and improvements	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	161,310,000	'	161,310,000	'	102,187,000
Leasehold improvements	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	10,311,000	'	10,311,000	'	9,302,000
Equipment and tooling	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	154,799,000	'	154,799,000	'	135,437,000
Furniture and fixtures	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	4,103,000	'	4,103,000	'	3,551,000
Computer equipment	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	16,970,000	'	16,970,000	'	14,309,000
Computer software	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	15,416,000	'	15,416,000	'	15,209,000
Construction in process	'	'	'	'	'
Property and equipment	'	'	'	'	'
Property and equipment, gross	$11,996,000	'	$11,996,000	'	$48,713,000

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	$83,743
Goodwill acquired or adjusted during the period	7,333
Foreign currency translation adjustment	1,120
Balance at the end of the period	92,196
Security	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	28,546
Goodwill acquired or adjusted during the period	784
Foreign currency translation adjustment	222
Balance at the end of the period	29,552
Healthcare	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	35,827
Goodwill acquired or adjusted during the period	1,018
Foreign currency translation adjustment	299
Balance at the end of the period	37,144
Optoelectronics and Manufacturing	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	19,370
Goodwill acquired or adjusted during the period	5,531
Foreign currency translation adjustment	599
Balance at the end of the period	$25,500

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets (Details 2) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	$56,049,000	'	$56,049,000	'	$53,988,000
Accumulated Amortization	27,313,000	'	27,313,000	'	28,003,000
Intangibles Net	28,736,000	'	28,736,000	'	25,985,000
Total intangible assets	'	'	'	'	'
Gross Carrying Value	68,038,000	'	68,038,000	'	64,606,000
Intangibles Net	40,725,000	'	40,725,000	'	36,603,000
Amortization expense	1,000,000	1,200,000	3,500,000	3,500,000	'
Estimated future amortization expense	'	'	'	'	'
2014 (remaining 3 months)	820,000	'	820,000	'	'
2015	2,911,000	'	2,911,000	'	'
2016	3,150,000	'	3,150,000	'	'
2017	2,782,000	'	2,782,000	'	'
2018	2,633,000	'	2,633,000	'	'
2019	2,532,000	'	2,532,000	'	'
2020 and thereafter, including assets that have not yet begun to be amortized	13,908,000	'	13,908,000	'	'
Intangibles Net	28,736,000	'	28,736,000	'	25,985,000
Trademarks	'	'	'	'	'
Non-amortizable assets -	'	'	'	'	'
Gross Carrying Value	11,989,000	'	11,989,000	'	10,618,000
Software development costs	'	'	'	'	'
Intangible assets	'	'	'	'	'
Weighted Average Lives	'	'	'7 years	'	'
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	19,764,000	'	19,764,000	'	17,350,000
Accumulated Amortization	6,473,000	'	6,473,000	'	5,396,000
Intangibles Net	13,291,000	'	13,291,000	'	11,954,000
Estimated future amortization expense	'	'	'	'	'
Intangibles Net	13,291,000	'	13,291,000	'	11,954,000
Capitalized software development costs	500,000	1,200,000	2,200,000	2,900,000	'
Patents	'	'	'	'	'
Intangible assets	'	'	'	'	'
Weighted Average Lives	'	'	'13 years	'	'
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	6,320,000	'	6,320,000	'	5,400,000
Accumulated Amortization	732,000	'	732,000	'	635,000
Intangibles Net	5,588,000	'	5,588,000	'	4,765,000
Estimated future amortization expense	'	'	'	'	'
Intangibles Net	5,588,000	'	5,588,000	'	4,765,000
Core technology	'	'	'	'	'
Intangible assets	'	'	'	'	'
Weighted Average Lives	'	'	'10 years	'	'
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	2,235,000	'	2,235,000	'	2,058,000
Accumulated Amortization	2,043,000	'	2,043,000	'	1,728,000
Intangibles Net	192,000	'	192,000	'	330,000
Estimated future amortization expense	'	'	'	'	'
Intangibles Net	192,000	'	192,000	'	330,000
Developed technology	'	'	'	'	'
Intangible assets	'	'	'	'	'
Weighted Average Lives	'	'	'11 years	'	'
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	16,360,000	'	16,360,000	'	20,002,000
Accumulated Amortization	11,347,000	'	11,347,000	'	14,620,000
Intangibles Net	5,013,000	'	5,013,000	'	5,382,000
Estimated future amortization expense	'	'	'	'	'
Intangibles Net	5,013,000	'	5,013,000	'	5,382,000
Customer relationships/backlog	'	'	'	'	'
Intangible assets	'	'	'	'	'
Weighted Average Lives	'	'	'7 years	'	'
Amortizable assets:	'	'	'	'	'
Gross Carrying Value	11,370,000	'	11,370,000	'	9,178,000
Accumulated Amortization	6,718,000	'	6,718,000	'	5,624,000
Intangibles Net	4,652,000	'	4,652,000	'	3,554,000
Estimated future amortization expense	'	'	'	'	'
Intangibles Net	$4,652,000	'	$4,652,000	'	$3,554,000

Borrowings_Details

Borrowings (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Sep. 30, 2012	Mar. 31, 2014
			Revolving credit facility	Revolving credit facility	Revolving credit facility	Revolving credit facility	Bank lines-of-credit	Seven-year term loan due in fiscal 2020	Seven-year term loan due in fiscal 2020	Seven-year term loan due in fiscal 2020
				LIBOR	LIBOR	LIBOR				LIBOR
					Minimum	Maximum
Borrowings	'	'	'	'	'	'	'	'	'	'
Maximum borrowing capacity	'	'	$425,000,000	'	'	'	'	'	'	'
Sub-limit available for letters of credit	'	'	375,000,000	'	'	'	'	'	'	'
Increase in the credit agreement's borrowing capacity available under certain circumstances	'	'	100,000,000	'	'	'	'	'	'	'
Variable basis rate	'	'	'	'LIBOR	'	'	'	'	'	'LIBOR
Interest rate margin (as a percent)	'	'	'	1.50%	1.50%	2.00%	'	'	'	1.25%
Unused commitment fee (as a percent)	'	'	0.25%	'	'	'	'	'	'	'
Amount outstanding	22,000,000	59,000,000	22,000,000	'	'	'	0	'	'	'
Amount outstanding under letters-of-credit sub-facility	'	'	112,000,000	'	'	'	5,800,000	'	'	'
Available credit facility	'	'	'	'	'	'	35,800,000	'	'	'
Total cash borrowing sub-limit	'	'	'	'	'	'	3,200,000	'	'	'
Principal amount	'	'	'	'	'	'	'	'	11,100,000	'
Term of loan	'	'	'	'	'	'	'	'7 years	'	'
Effective interest rate (as a percent)	'	'	'	'	'	'	'	2.20%	'	'
Term loans	11,316,000	12,470,000	'	'	'	'	'	'	'	'
Other long-term debt	2,310,000	'	'	'	'	'	'	'	'	'
Long-term debt	13,626,000	12,470,000	'	'	'	'	'	'	'	'
Less current portion of long-term debt	2,779,000	1,797,000	'	'	'	'	'	'	'	'
Long-term portion of debt	$10,847,000	$10,673,000	'	'	'	'	'	'	'	'

Impairment_Restructuring_and_O2

Impairment, Restructuring and Other Charges (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Restructuring and other charges	'
Balance at the beginning of the period	$2,748
Total expensed during the period	8,925
Paid or incurred during the period	8,171
Balance at the end of the period	3,502
Facility closures	'
Restructuring and other charges	'
Total expensed during the period	2,772
Employee termination costs	'
Restructuring and other charges	'
Total expensed during the period	1,491
Charges related to government contract issues	'
Restructuring and other charges	'
Total expensed during the period	4,298
Charges related to class action litigation	'
Restructuring and other charges	'
Total expensed during the period	364
Security	'
Restructuring and other charges	'
Balance at the beginning of the period	1,043
Total expensed during the period	5,120
Paid or incurred during the period	4,546
Balance at the end of the period	1,617
Security | Employee termination costs	'
Restructuring and other charges	'
Total expensed during the period	822
Security | Charges related to government contract issues	'
Restructuring and other charges	'
Total expensed during the period	4,298
Healthcare	'
Restructuring and other charges	'
Balance at the beginning of the period	1,639
Total expensed during the period	2,009
Paid or incurred during the period	2,046
Balance at the end of the period	1,602
Healthcare | Facility closures	'
Restructuring and other charges	'
Total expensed during the period	2,009
Optoelectronics and Manufacturing	'
Restructuring and other charges	'
Balance at the beginning of the period	66
Total expensed during the period	1,432
Paid or incurred during the period	1,215
Balance at the end of the period	283
Optoelectronics and Manufacturing | Facility closures	'
Restructuring and other charges	'
Total expensed during the period	763
Optoelectronics and Manufacturing | Employee termination costs	'
Restructuring and other charges	'
Total expensed during the period	669
Corporate	'
Restructuring and other charges	'
Total expensed during the period	364
Paid or incurred during the period	364
Corporate | Charges related to class action litigation	'
Restructuring and other charges	'
Total expensed during the period	$364

Stockbased_Compensation_Detail

Stock-based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
			Item
Stock-based Compensation	'	'	'	'
Number of share-based employee compensation plans	'	'	2	'
Stock based compensation expense	'	'	'	'
Stock-based compensation expense before taxes	$3,254,000	$4,336,000	$13,975,000	$11,482,000
Less: related income tax benefit	1,319,000	1,656,000	5,457,000	4,364,000
Stock-based compensation expense, net of estimated taxes	1,935,000	2,680,000	8,518,000	7,118,000
Stock Options	'	'	'	'
Stock-based compensation, other disclosures	'	'	'	'
Unrecognized compensation cost	1,300,000	'	1,300,000	'
Weighted-average period	'	'	'1 year 7 months 6 days	'
Restricted stock and RSU	'	'	'	'
Stock-based compensation, other disclosures	'	'	'	'
Unrecognized compensation cost	18,700,000	'	18,700,000	'
Weighted-average period	'	'	'2 years	'
Cost of goods sold	'	'	'	'
Stock based compensation expense	'	'	'	'
Stock-based compensation expense before taxes	180,000	335,000	705,000	601,000
Selling, general and administrative	'	'	'	'
Stock based compensation expense	'	'	'	'
Stock-based compensation expense before taxes	3,057,000	3,944,000	13,130,000	10,709,000
Research and development	'	'	'	'
Stock based compensation expense	'	'	'	'
Stock-based compensation expense before taxes	$17,000	$57,000	$140,000	$172,000

Stockbased_Compensation_Detail1

Stock-based Compensation (Details 2) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
2012 Plan	'	'
Weighted-Average Fair Value	'	'
Securities available for grant	3,222,921	'
Stock Options	'	'
Number of Options	'	'
Outstanding at the beginning of the period (in shares)	1,019,733	'
Granted (in shares)	10,294	'
Exercised (in shares)	-1,169	'
Expired or forfeited (in shares)	-4,646	'
Outstanding at the end of the period (in shares)	1,024,212	'
Exercisable at the end of the period (in shares)	845,805	'
Weighted-Average Exercise Price	'	'
Outstanding at the beginning of the period (in dollars per share)	26.33	'
Granted (in dollars per share)	70.59	'
Exercised (in dollars per share)	39.97	'
Expired or forfeited (in dollars per share)	54.07	'
Outstanding at the end of the period (in dollars per share)	26.63	'
Exercisable at the end of the period (in dollars per share)	22.55	'
Weighted-Average Remaining Contractual Term	'	'
Outstanding at the end of the period	'5 years 10 months 24 days	'
Exercisable at the end of the period	'5 years 4 months 24 days	'
Aggregate Intrinsic Value	'	'
Outstanding at the end of the period	34,144	'
Exercisable at the end of the period	31,537	'
Restricted stock and RSU	'	'
Shares	'	'
Nonvested at the beginning of the period (in shares)	627,124	'
Granted (in shares)	322,275	'
Vested (in shares)	-276,716	'
Forfeited (in shares)	-3,992	'
Nonvested at the end of the period (in shares)	668,691	'
Weighted-Average Fair Value	'	'
Nonvested at the beginning of the period (in dollars per share)	43.19	'
Granted (in dollars per share)	63.73	'
Vested (in dollars per share)	39.16	'
Forfeited (in dollars per share)	49.23	'
Nonvested at the end of the period (in dollars per share)	54.73	'
Restricted stock and RSU | 2012 Plan	'	'
Weighted-Average Fair Value	'	'
Number of shares available for grant reduced for each share granted	1.87	'
Number of shares available for grant increased for each share forfeited and returned	1.87	'
Performance-based restricted stock units	'	'
Shares	'	'
Granted (in shares)	160,922	178,500
Performance-based restricted stock units | Minimum	'	'
Weighted-Average Fair Value	'	'
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock	0.00%	'
Performance-based restricted stock units | Maximum	'	'
Weighted-Average Fair Value	'	'
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock	250.00%	'

Retirement_Benefit_Plans_Detai

Retirement Benefit Plans (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Net Periodic Benefit Costs	'	'	'	'
Service cost	$288,000	$269,000	$890,000	$853,000
Amortization of prior service cost	202,000	229,000	606,000	689,000
Net periodic pension expense	490,000	498,000	1,496,000	1,542,000
Contributions made by the entity to the defined benefit plans	100,000	100,000	1,000,000	100,000
Contributions made by the entity to defined contribution plans	$1,000,000	$900,000	$3,000,000	$2,700,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	9 Months Ended						9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2014
	Item			Mexican government	Mexican government	Maximum	Royalty payments
							Item
Contingent Acquisition Obligations	'	'	'	'	'	'	'
Maximum amount of future payments under contingent consideration	'	'	'	'	'	$51,000,000	'
Purchase agreements containing royalty payments, number	'	'	'	'	'	'	1
Fair value of contingent payment obligations	18,500,000	'	15,400,000	'	'	'	'
Advances from Customers	'	'	'	'	'	'	'
Advances from customers	'	'	'	81,300,000	100,000,000	'	'
Environmental Contingencies	'	'	'	'	'	'	'
Number of investigations discovering soil and groundwater contamination at Hawthorne, CA facility	1	'	'	'	'	'	'
Changes in provision for warranties	'	'	'	'	'	'	'
Balance at beginning of period	12,890,000	17,562,000	'	'	'	'	'
Warrantee claims provision	3,306,000	1,195,000	'	'	'	'	'
Settlements made	-4,840,000	-4,794,000	'	'	'	'	'
Balance at end of period	$11,356,000	$13,963,000	'	'	'	'	'

Income_Taxes_Details

Income Taxes (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2014
Income Taxes	'	'
Effective tax rate as a result of accelerating depreciation of certain foreign assets (as a percent)	71.20%	44.20%
Effective tax rate using regular depreciation (as a percent)	25.30%	27.70%

Segment_Information_Details

Segment Information (Details)	9 Months Ended
	Mar. 31, 2014
	Item
Segment Information	'
Number of identifiable industry segments	3

Segment_Information_Details_2

Segment Information (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Operations and identifiable assets by industry segment	'	'	'	'	'
Revenues	$203,956	$198,409	$646,638	$574,152	'
Operating income (loss)	18,022	19,414	50,524	48,206	'
Assets	939,747	'	939,747	'	919,796
One customer | Revenues | Customer	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Percentage of benchmark derived from specified source	16.00%	14.00%	15.00%	8.00%	'
Corporate	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Operating income (loss)	-3,488	-4,017	-11,888	-9,704	'
Assets	88,825	'	88,825	'	75,496
Operating Segments | Security division	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Revenues	95,007	99,840	298,748	274,619	'
Operating income (loss)	14,213	16,179	40,984	29,251	'
Assets	505,334	'	505,334	'	499,539
Operating Segments | Healthcare division	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Revenues	52,188	51,357	161,081	159,052	'
Operating income (loss)	4,084	3,593	11,312	14,389	'
Assets	172,136	'	172,136	'	190,963
Operating Segments | Optoelectronics and Manufacturing division, including intersegment revenues	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Revenues	66,331	54,761	214,000	169,185	'
Operating income (loss)	3,414	3,271	10,300	13,561	'
Assets	178,421	'	178,421	'	158,584
Eliminations	'	'	'	'	'
Operations and identifiable assets by industry segment	'	'	'	'	'
Revenues	-9,570	-7,549	-27,191	-28,704	'
Operating income (loss)	-201	388	-184	709	'
Assets	($4,969)	'	($4,969)	'	($4,786)